Brenntag, a chemical and ingredient distributor, announced an agreement to acquire Colony Gums, Inc., a U.S. based manufacturer of stabilized blends and a blending services provider. The acquisition will expand Brenntag’s product portfolio and services in life sciences, primarily in nutrition.
 
“Colony Gums will complement our existing business and enable us to serve customers with stabilizer blends, blending solutions and hydrocolloids in our growth market of Nutrition, and other customers in Life Sciences markets globally,” said Michael Friede, CEO of Brenntag Specialties. “This is part of our ‘Strategy to Win’ to expand and fill white spots in our Life Science portfolio.”

“I look forward to working with our new colleagues in Monroe and am excited to welcome them to the Brenntag team,” he added.
 
Colony Gums is a family-owned distributor headquartered in Monroe, North Carolina. The company has grown into a specialty ingredients supplier with more than 30 employees, and achieved annual sales of $38 million in 2022.
 
”Our team strives to enable customer growth and exceeding the expectations of our customers. I am excited to bring Brenntag customers our formulation expertise on stabilizer blends and individual hydrocolloids, and adding Brenntag’s broad portfolio of products and solutions to our offerings,” said Robert Muhlsteff, president of Colony Gums.
 
The closing of the transaction is subject to customary conditions, including regulatory approvals, and is expected in Q4 of 2023.